Administration of high-dose four-factor prothrombin complex concentrate for Xa inhibitor reversal to prevent expansion of intracranial hemorrhage with computed tomography angiography spot sign: a case report
-
- Totsuka Takeaki
- Department of Neurosurgery, Seirei Mikatahara General Hospital
-
- Akamine Soichi
- Department of Strokology, Seirei Mikatahara General Hospital
-
- Kuroda Naoto
- Department of Neurosurgery, Seirei Mikatahara General Hospital
-
- Sato Haruhiko
- Department of Neurosurgery, Seirei Mikatahara General Hospital
Bibliographic Information
- Other Title
-
- CTA spot sign を有するXa 阻害薬内服患者の脳出血に対して高用量の4factor-prothrombin complex concentrate(4F-PCC)を投与した1 例
Search this article
Abstract
<p>A 69-year-old woman presented with consciousness disturbance, and she was admitted to our hospital. She had taken a Xa inhibitor (rivaroxaban) for non-valvular atrial fibrillation. Head computed tomography revealed a large subcortical hemorrhage in the left temporal lobe and uncal herniation. Computed tomography angiography revealed a spot sign in the hematoma. To prevent hematoma expansion, we administered a high-dose four-factor prothrombin complex concentrate (4F-PCC). Immediately after 4F-PCC administration, her prothrombin time (PT) and PT-INR completely normalized. Subsequently, we performed craniotomy and evacuated the hematoma. After the surgery, her consciousness disturbance completely resolved. Eventually, she was transferred to a rehabilitation hospital owing to cognitive dysfunction.</p>
Journal
-
- Japanese Journal of Stroke
-
Japanese Journal of Stroke 42 (5), 418-422, 2020
The Japan Stroke Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390285697598888704
-
- NII Article ID
- 130007907575
-
- ISSN
- 18831923
- 09120726
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed